Can the gut microbiome inform the effects of omega-3 fatty acid supplementation trials on cognition?
Journal
Current opinion in clinical nutrition and metabolic care
ISSN: 1473-6519
Titre abrégé: Curr Opin Clin Nutr Metab Care
Pays: England
ID NLM: 9804399
Informations de publication
Date de publication:
26 Dec 2023
26 Dec 2023
Historique:
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
aheadofprint
Résumé
Most omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation clinical trials report inconsistent or null findings on measures of cognition or Alzheimer's disease (AD) with a relatively large variability in the response to n-3 PUFA supplementation. The purpose of this review is to identify whether the gut microbiome together with the metabolome can provide critical insights to understand this heterogeneity in the response to n-3 PUFA supplementation. A Western diet with high saturated fat and omega-6 fatty acid content, obesity, and lack of exercise puts strain on the gut microbiome resulting in imbalance, dysbiosis, reduced bacterial diversity, and increased abundance of the pro-inflammatory taxa. A plant-based diet has beneficial effects on the gut microbiota even when deficient in n-3 PUFAs. Human and animal studies show that increased intake of the n-3 PUFAs correlates with increased beneficial intestinal bacteria when compared to a Western diet. The composition of the gut microbiota can help define the effects of n-3 PUFA supplementation on the brain and lead to more personalized nutritional interventions.
Identifiants
pubmed: 38170690
doi: 10.1097/MCO.0000000000001007
pii: 00075197-990000000-00129
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Sherzai AZ, Sherzai AN, Sherzai D. A systematic review of omega-3 consumption and neuroprotective cognitive outcomes. Am J Lifestyle Med 2023; 17:560–588.
Patch CS, Hill-Yardin EL, Lewis M, et al. The more, the better: high-dose omega-3 fatty acids improve behavioural and molecular outcomes in preclinical models in mild brain injury. Curr Neurol Neurosci Rep 2021; 21:45.
Samieri C, Yassine HN, Melo van Lent D, et al. Personalized nutrition for dementia prevention. Alzheimers Dement 2022; 18:1424–1437.
Peters R, Dodge HH, James S, et al. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven’t lived up to expectations, and where do we go from here? Alzheimers Dement 2022; 18:507–512.
Tomata Y, Larsson SC, Hägg S. Polyunsaturated fatty acids and risk of Alzheimer's disease: a Mendelian randomization study. Eur J Nutr 2020; 59:1763–1766.
Askarova S, Umbayev B, Masoud AR, et al. The links between the gut microbiome, aging, modern lifestyle and Alzheimer's disease. Front Cell Infect Microbiol 2020; 10:104.
Lee D, Lee VM, Hur SK. Manipulation of the diet-microbiota-brain axis in Alzheimer's disease. Front Neurosci 2022; 16:1042865.
Lin L, Zheng LJ, Zhang LJ. Neuroinflammation, gut microbiome, and Alzheimer's disease. Mol Neurobiol 2018; 55:8243–8250.
Zhao Y, Jaber V, Lukiw WJ. Gastrointestinal tract microbiome-derived pro-inflammatory neurotoxins in Alzheimer's disease. J Aging Sci 2021; 9: (Suppl 5): 002.
Gynther M, Estrada ML, Loppi S, et al. Increased expression and activity of brain cortical cPLA2 due to chronic lipopolysaccharide administration in mouse model of familial Alzheimer's disease. Pharmaceutics 2022; 14:2438.
Ebright B, Assante I, Poblete RA, et al. Eicosanoid lipidome activation in postmortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther 2022; 14:152.
Vogt NM, Kerby RL, Dill-McFarland KA, et al. Gut microbiome alterations in Alzheimer's disease. Sci Rep 2017; 7:13537.
Zhuang ZQ, Shen LL, Li WW, et al. Gut microbiota is altered in patients with Alzheimer's disease. J Alzheimers Dis 2018; 63:1337–1346.
Chun C, Jianming L, Yiyuan X, et al. Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut 2022; 71:2233–2252.
Grabrucker S, Marizzoni M, Silajdžić E, et al. Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis. Brain 2023; 146:4916–4934.
Harach T, Marungruang N, Duthilleul N, et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep 2017; 7:41802.
Zhang T, Gao G, Kwok LY, Sun Z. Gut microbiome-targeted therapies for Alzheimer's disease. Gut Microbes 2023; 15:2271613.
Seo DO, O’Donnell D, Jain N, et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 2023; 379:eadd1236.
Tsai JH, Huang CF, Lin MN, et al. Taiwanese vegetarians are associated with lower dementia risk: a prospective cohort study. Nutrients 2022; 14:588.
Buettner D, Skemp S. Blue zones: lessons from the world's longest lived. Am J Lifestyle Med 2016; 10:318–321.
Sherchan P, Miles F, Orlich M, et al. Effects of lifestyle factors on cognitive resilience: commentary on ‘what this sunny, religious town in California teaches us about living longer’. Transl Stroke Res 2020; 11:161–164.
Miles FL, Orlich MJ, Mashchak A, et al. The biology of veganism: plasma metabolomics analysis reveals distinct profiles of vegans and non-vegetarians in the Adventist Health Study-2 cohort. Nutrients 2022; 14:709.
Rosell MS, Lloyd-Wright Z, Appleby PN, et al. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr 2005; 82:327–334.
Tomova A, Bukovsky I, Rembert E, et al. The effects of vegetarian and vegan diets on gut microbiota. Front Nutr 2019; 6:47.
Losasso C, Eckert EM, Mastrorilli E, et al. Assessing the influence of vegan, vegetarian and omnivore oriented westernized dietary styles on human gut microbiota: a cross sectional study. Front Microbiol 2018; 9:317.
Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med 2017; 15:73.
Wang X, Qi Y, Zheng H. Dietary polyphenol, gut microbiota, and health benefits. Antioxidants (Basel) 2022; 11:1212.
Wang S, Li B, Solomon V, et al. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener 2022; 17:42.
Ma QL, Zhu C, Morselli M, et al. The novel omega-6 fatty acid docosapentaenoic acid positively modulates brain innate immune response for resolving neuroinflammation at early and late stages of humanized APOE-Based Alzheimer's disease models. Front Immunol 2020; 11:558036.
Johnson GH, Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J Acad Nutr Diet 2012; 112:1029–1041. 1041.e1–15.
Palavicini JP, Wang C, Chen L, et al. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A 2 in a spatial-specific manner. Acta Neuropathol Commun 2017; 5:56.
Esposito G, Giovacchini G, Liow JS, et al. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET, Journal of nuclear medicine: official publication. Soc Nucl Med 2008; 49:1414–1421.
Soliman ML, Ohm JE, Rosenberger TA. Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide. Lipids 2013; 48:651–662.
Watson H, Mitra S, Croden FC, et al. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut 2018; 67:1974–1983.
Noriega BS, Sanchez-Gonzalez MA, Salyakina D, Coffman J. Understanding the impact of omega-3 rich diet on the gut microbiota. Case Rep Med 2016; 2016:3089303.
Dong R, Lin H, Ding Y, et al. Effects of docosahexanoic acid on gut microbiota and fecal metabolites in HIV-infected patients with neurocognitive impairment: a 6-month randomized, double-blind, placebo-controlled trial. Front Nutr 2021; 8:756720.
Menni C, Zierer J, Pallister T, et al. Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women. Sci Rep 2017; 7:11079.
Che H, Li H, Song L, et al. Orally administered DHA-enriched phospholipids and DHA-enriched triglyceride relieve oxidative stress, improve intestinal barrier, modulate inflammatory cytokine and gut microbiota, and meliorate inflammatory responses in the brain in dextran sodium sulfate induced colitis in mice. Mol Nutr Food Res 2021; 65:e2000986.
Zhang J, Yi C, Han J, et al. Novel high-docosahexaenoic-acid tuna oil supplementation modulates gut microbiota and alleviates obesity in high-fat diet mice. Food Sci Nutr 2020; 8:6513–6527.
Kaliannan K, Wang B, Li XY, et al. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep 2015; 5:11276.
Caesar R, Tremaroli V, Kovatcheva-Datchary P, et al. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 2015; 22:658–668.
Mujico JR, Baccan GC, Gheorghe A, et al. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. Br J Nutr 2013; 110:711–720.
Ghosh S, DeCoffe D, Brown K, et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One 2013; 8:e55468.
Lu X, Zhong R, Hu L, et al. DHA-enriched phospholipids from large yellow croaker roe regulate lipid metabolic disorders and gut microbiota imbalance in SD rats with a high-fat diet. Food Funct 2021; 12:4825–4841.
Rajkumar H, Mahmood N, Kumar M, et al. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediators Inflamm 2014; 2014:348959.
Balfegó M, Canivell S, Hanzu FA, et al. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial. Lipids Health Dis 2016; 15:78.
Hosomi R, Matsudo A, Sugimoto K, et al. Dietary eicosapentaenoic acid and docosahexaenoic acid ethyl esters influence the gut microbiota and bacterial metabolites in Rats. J Oleo Sci 2021; 70:1469–1480.
Pu S, Khazanehei H, Jones PJ, Khafipour E. Interactions between obesity status and dietary intake of monounsaturated and polyunsaturated oils on human gut microbiome profiles in the Canola Oil Multicenter Intervention Trial (COMIT). Front Microbiol 2016; 7:1612.
Yassine H, Arellanes IC, Mazmanian A, et al. Baseline findings of PreventE4: a double-blind placebo controlled clinical trial testing high dose DHA in APOE4 carriers before the onset of dementia. J Prev Alzheimers Dis 2023; 10:810–820.
Miao Z, Chen GD, Huo S, et al. Interaction of n-3 polyunsaturated fatty acids with host CD36 genetic variant for gut microbiome and blood lipids in human cohorts. Clin Nutr 2022; 41:1724–1734.
Yu HN, Zhu J, Pan WS, et al. Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Arch Med Res 2014; 45:195–202.